A
Adrian Parker
Researcher at Wellcome Trust Sanger Institute
Publications - 11
Citations - 12876
Adrian Parker is an academic researcher from Wellcome Trust Sanger Institute. The author has contributed to research in topics: Mutation & Cancer. The author has an hindex of 11, co-authored 11 publications receiving 12076 citations. Previous affiliations of Adrian Parker include Wellcome Trust.
Papers
More filters
Journal ArticleDOI
Mutations of the BRAF gene in human cancer
Helen Davies,Graham R. Bignell,Charles Cox,Philip J. Stephens,Sarah Edkins,S. M. Clegg,Jon W. Teague,Hayley Woffendin,Mathew J. Garnett,William Bottomley,Neil Davis,Ed Dicks,Rebecca Ewing,Yvonne Floyd,Kristian Gray,S. Hall,Rachel Hawes,Jaime Hughes,Vivian Kosmidou,Andrew Menzies,Catherine Mould,Adrian Parker,Claire Stevens,Stephen Watt,Steven Hooper,Rebecca Wilson,Hiran Jayatilake,Barry A. Gusterson,Colin Cooper,Janet Shipley,Darren Hargrave,Kathy Pritchard-Jones,Norman J. Maitland,Georgia Chenevix-Trench,Gregory J. Riggins,Darell D. Bigner,Giuseppe Palmieri,Antonio Cossu,Adrienne M. Flanagan,Andrew G. Nicholson,Judy W. C. Ho,Suet Yi Leung,Siu Tsan Yuen,Barbara L. Weber,Hilliard F. Seigler,Timothy L. Darrow,Hugh Paterson,Richard Marais,Christopher J. Marshall,Richard Wooster,Michael R. Stratton,P. Andrew Futreal +51 more
TL;DR: BRAF somatic missense mutations in 66% of malignant melanomas and at lower frequency in a wide range of human cancers, with a single substitution (V599E) accounting for 80%.
Journal ArticleDOI
Lung cancer: intragenic ERBB2 kinase mutations in tumours.
Philip J. Stephens,Christopher I. Hunter,Graham R. Bignell,Sarah Edkins,Helen Davies,Jon W. Teague,Claire Stevens,Sarah O’Meara,Raffaella Smith,Adrian Parker,Andy Barthorpe,Matthew J. Blow,Lisa Brackenbury,Adam Butler,Oliver Clarke,Jennifer Cole,Ed Dicks,Angus Dike,Anja Drozd,Ken Edwards,Simon A. Forbes,Rebecca Foster,Kristian Gray,Christopher Greenman,Kelly Halliday,Katy Hills,Vivienne Kosmidou,Richard Lugg,Andy Menzies,Janet Perry,Robert Petty,Keiran Raine,Lewis Ratford,Rebecca Shepherd,Alexandra Small,Yvonne Stephens,Calli Tofts,Jennifer Varian,Sofie West,Sara Widaa,Andrew D. Yates,Francis Brasseur,Colin Cooper,Adrienne M. Flanagan,Margaret A. Knowles,Suet Yi Leung,David N. Louis,Leendert H. J. Looijenga,Bruce Malkowicz,Marco A. Pierotti,Bin Teh,Georgia Chenevix-Trench,Barbara L. Weber,Siu Tsan Yuen,Grace Harris,Peter Goldstraw,Andrew G. Nicholson,P. Andrew Futreal,Richard Wooster,Michael R. Stratton,Michael R. Stratton +60 more
TL;DR: The protein-kinase family is the most frequently mutated gene family found in human cancer and faulty kinase enzymes are being investigated as promising targets for the design of antitumour therapies as mentioned in this paper.
Journal ArticleDOI
Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer
Helen Davies,Christopher I. Hunter,Raffaella Smith,Philip J. Stephens,Christopher Greenman,Graham R. Bignell,Jon W. Teague,Adam Butler,Sarah Edkins,Claire Stevens,Adrian Parker,Sarah O’Meara,Tim Avis,Syd Barthorpe,Lisa Brackenbury,Gemma Buck,Jody Clements,Jennifer Cole,Ed Dicks,Ken Edwards,Simon A. Forbes,Matthew Gorton,Kristian Gray,Kelly Halliday,Rachel Harrison,Katy Hills,Jonathon Hinton,David Jones,Vivienne Kosmidou,Ross Laman,Richard Lugg,Andrew Menzies,Janet Perry,Robert Petty,Keiran Raine,Rebecca Shepherd,Alexandra Small,Helen Solomon,Yvonne Stephens,Calli Tofts,Jennifer Varian,Anthony Webb,Sofie West,Sara Widaa,Andrew D. Yates,Francis Brasseur,Colin Cooper,Adrienne M. Flanagan,Anthony R. Green,Maggie Knowles,Suet Yi Leung,Leendert H. J. Looijenga,Bruce Malkowicz,Marco A. Pierotti,Bin Tean Teh,Siu Tsan Yuen,Sunil R. Lakhani,Douglas F. Easton,Barbara L. Weber,Peter Goldstraw,Andrew G. Nicholson,Richard Wooster,Richard Wooster,Michael R. Stratton,P. Andrew Futreal +64 more
TL;DR: The results suggest that several mutated protein kinases may be contributing to lung cancer development, but that mutations in each one are infrequent.
Journal ArticleDOI
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.
Ogechi Ikediobi,Helen Davies,Graham R. Bignell,Sarah Edkins,Claire Stevens,Sarah O’Meara,Thomas Santarius,Tim Avis,Syd Barthorpe,Lisa Brackenbury,Gemma Buck,Adam Butler,Jody Clements,Jennifer Cole,Ed Dicks,Simon A. Forbes,Kristian Gray,Kelly Halliday,Rachel Harrison,Katy Hills,Jonathan Hinton,Christopher I. Hunter,Andy Jenkinson,David T. Jones,Vivienne Kosmidou,Richard Lugg,Andrew Menzies,Tatiana Mironenko,Adrian Parker,Janet Perry,Keiran Raine,David S. Richardson,Rebecca Shepherd,Alex Small,Raffaella Smith,Helen Solomon,Philip J. Stephens,Jon W. Teague,Calli Tofts,Jennifer Varian,Tony Webb,Sofie West,Sara Widaa,Andrew D. Yates,William C. Reinhold,John N. Weinstein,Michael R. Stratton,P. Andrew Futreal,Richard Wooster +48 more
TL;DR: Identification of those cancer genes mutated in the NCI-60, in combination with pharmacologic and molecular profiles of the cells, will allow for more informed interpretation of anticancer agent screening and will enhance the use of the NCi-60 cell lines for molecularly targeted screens.
Journal ArticleDOI
A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy
Christopher I. Hunter,Raffaella Smith,Daniel P. Cahill,Philip J. Stephens,Claire Stevens,Jon W. Teague,Christopher Greenman,Sarah Edkins,Graham R. Bignell,Helen Davies,Sarah O’Meara,Adrian Parker,Tim Avis,Syd Barthorpe,Lisa Brackenbury,Gemma Buck,Adam Butler,Jody Clements,Jennifer Cole,Ed Dicks,Simon A. Forbes,Matthew Gorton,Kristian Gray,Kelly Halliday,Rachel Harrison,Katy Hills,Jonathon Hinton,Andy Jenkinson,David T. Jones,Vivienne Kosmidou,Ross Laman,Richard Lugg,Andrew Menzies,Janet Perry,Robert Petty,Keiran Raine,David S. Richardson,Rebecca Shepherd,Alexandra Small,Helen Solomon,Calli Tofts,Jennifer Varian,Sofie West,Sara Widaa,Andrew D. Yates,Douglas F. Easton,Gregory J. Riggins,Jennifer E. Roy,Kymberly K. Levine,Wolf Mueller,Tracy T. Batchelor,David N. Louis,Michael R. Stratton,P. Andrew Futreal,Richard Wooster +54 more
TL;DR: The evidence suggests that when MSH6 is inactivated in gliomas, alkylating agents convert from induction of tumor cell death to promotion of neoplastic progression, and the potential of large scale sequencing for revealing and elucidating mutagenic processes operative in individual human cancers is highlighted.